首页 > 最新文献

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru最新文献

英文 中文
Endoscopic features of drug-induced esophageal ulcer: "the kissing ulcer". 药物性食管溃疡的内镜特征:“接吻溃疡”。
Felipe Silva, Gonzalo Latorre, Alberto Espino

Drug-induced esophageal ulcers constitute an acquired chemical injury to the esophageal mucosa, most frequently associated with tetracyclines, particularly doxycycline. We report a case of "kissing ulcers" diagnosed through esophagogastroduodenoscopy in a young woman undergoing doxycycline treatment for rosacea. The pathogenesis is linked to drug-specific factors, such as caustic effects, hyperosmolar properties, and prolonged mucosal contact with the medication, in addition to patient-specific risks, including esophageal motility disorders, reduced saliva production, and mid-esophageal anatomical compression. Clinically, patients commonly present with abrupt-onset chest pain, dysphagia, and odynophagia, while endoscopic findings often reveal mucosal erythema, erosions, and specular distribution esophageal ulcers (referred to as "kissing ulcers"). Management involves discontinuation of the causative drug, initiation of proton pump inhibitors or sucralfate, and implementation of preventive measures, such as ensuring adequate hydration during medication intake. This condition is generally self-limiting, with symptoms resolving within two weeks, underscoring the importance of prompt diagnosis and treatment to avoid potential complications.

药物性食管溃疡是一种获得性的食管粘膜化学损伤,最常与四环素,尤其是强力霉素有关。我们报告一例“接吻溃疡”诊断通过食管胃十二指肠镜在一个年轻的妇女接受强力霉素治疗酒sacea。其发病机制与药物特异性因素有关,如腐蚀性作用、高渗透性和与药物的长时间粘膜接触,此外还有患者特异性风险,包括食管运动障碍、唾液分泌减少和食管中期解剖受压。临床上,患者通常表现为突发性胸痛、吞咽困难和吞咽困难,而内镜检查结果常显示粘膜红斑、糜烂和镜面分布的食管溃疡(称为“接吻溃疡”)。治疗包括停用致病性药物,开始使用质子泵抑制剂或硫硫酸盐,并实施预防措施,如在服药期间确保足够的水合作用。这种情况通常是自限性的,症状在两周内消退,强调了及时诊断和治疗以避免潜在并发症的重要性。
{"title":"Endoscopic features of drug-induced esophageal ulcer: \"the kissing ulcer\".","authors":"Felipe Silva, Gonzalo Latorre, Alberto Espino","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Drug-induced esophageal ulcers constitute an acquired chemical injury to the esophageal mucosa, most frequently associated with tetracyclines, particularly doxycycline. We report a case of \"kissing ulcers\" diagnosed through esophagogastroduodenoscopy in a young woman undergoing doxycycline treatment for rosacea. The pathogenesis is linked to drug-specific factors, such as caustic effects, hyperosmolar properties, and prolonged mucosal contact with the medication, in addition to patient-specific risks, including esophageal motility disorders, reduced saliva production, and mid-esophageal anatomical compression. Clinically, patients commonly present with abrupt-onset chest pain, dysphagia, and odynophagia, while endoscopic findings often reveal mucosal erythema, erosions, and specular distribution esophageal ulcers (referred to as \"kissing ulcers\"). Management involves discontinuation of the causative drug, initiation of proton pump inhibitors or sucralfate, and implementation of preventive measures, such as ensuring adequate hydration during medication intake. This condition is generally self-limiting, with symptoms resolving within two weeks, underscoring the importance of prompt diagnosis and treatment to avoid potential complications.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"56-59"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Risk Factors for metabolic fatty liver disease with high suspicion of advanced fibrosis in lean patients attended at the Hospital Nacional Dos de Mayo, 2012-2022]. [2012-2022年,在国立多斯梅奥医院就诊的瘦患者中,代谢性脂肪性肝病伴晚期纤维化的高危因素]。
Gonzalo Miranda Manrique, Herman Vildózola Gonzales

Objective: To determine the sociodemographic, anthropometric, biochemical-metabolic risk factors, and presence of comorbidities associated with metabolic hepatic steatosis with high suspicion of advanced fibrosis in thin patients compared to overweight or obese patients, treated at the Hospital Nacional Dos de Mayo 2012-2022.

Materials and methods: The sample included 160 patients, 80 cases and 80 controls from the medical records of patients treated in the Endocrinology Office. The research was quantitative, observational and analytical of cases and controls. It evaluated socio-demographic, clinical, biochemical variables and comorbidities. Descriptive analysis was used. Chi-square tests, calculation of OR, and confidence interval were applied, and logistic regression analysis was performed to evaluate confounding variables.

Results: Sociodemographic: 77.5% female and 36.3% over 60 years of age p<.05. Anthropometric: 52.5% had abnormal abdominal circumference. Biochemical: 83.8% HDL low p<0.05 OR 10.6; 68.8% hypercholesterolemia <0.05; 72.5% hypertriglyceridemia p<0.05 OR 1.78; 61.3% elevated HbA1c p=0.48; 86.3% elevated LDL p>0.05 and 93.8% Increased ferritin p<0.05 OR 11.8.

Clinical: Metabolic syndrome p<0.05 1.22 (0.9-1.44) and within the comorbidities 62.5% had diabetes mellitus p=0.26. After logistic regression analysis: Ferritin, decreased HDL and hypertriglyceridemia with a value of p<0.05.

Conclusions: Increased ferritin, decreased HDL, and hypertriglyceridemia influence the risk of developing metabolic dysfunction associated with steatohepatitis with advanced fibrosis in lean patients treated at the Hospital Nacional Dos de Mayo 2012-2022.

目的:确定2012-2022年在国立五月医院治疗的消瘦患者与超重或肥胖患者相比,与代谢性肝脂肪变性相关的社会人口学、人体测量学、生化代谢危险因素和合并症的存在。材料与方法:样本包括160例患者,80例病例和80例对照,来自内分泌科就诊的患者病历。研究是定量的,观察和分析病例和对照。它评估了社会人口统计学、临床、生化变量和合并症。采用描述性分析。采用卡方检验、OR计算和置信区间,并采用logistic回归分析评价混杂变量。结果:社会人口统计学:77.5%女性和36.3% 60岁以上p0.05和93.8%铁蛋白升高p临床:代谢综合征结论:铁蛋白升高、高密度脂蛋白降低和高甘油三酯血症影响2012-2022年在国立五月医院治疗的瘦患者脂肪性肝炎合并晚期纤维化相关代谢功能障碍的风险。
{"title":"[Risk Factors for metabolic fatty liver disease with high suspicion of advanced fibrosis in lean patients attended at the Hospital Nacional Dos de Mayo, 2012-2022].","authors":"Gonzalo Miranda Manrique, Herman Vildózola Gonzales","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To determine the sociodemographic, anthropometric, biochemical-metabolic risk factors, and presence of comorbidities associated with metabolic hepatic steatosis with high suspicion of advanced fibrosis in thin patients compared to overweight or obese patients, treated at the Hospital Nacional Dos de Mayo 2012-2022.</p><p><strong>Materials and methods: </strong>The sample included 160 patients, 80 cases and 80 controls from the medical records of patients treated in the Endocrinology Office. The research was quantitative, observational and analytical of cases and controls. It evaluated socio-demographic, clinical, biochemical variables and comorbidities. Descriptive analysis was used. Chi-square tests, calculation of OR, and confidence interval were applied, and logistic regression analysis was performed to evaluate confounding variables.</p><p><strong>Results: </strong>Sociodemographic: 77.5% female and 36.3% over 60 years of age p<.05. Anthropometric: 52.5% had abnormal abdominal circumference. Biochemical: 83.8% HDL low p<0.05 OR 10.6; 68.8% hypercholesterolemia <0.05; 72.5% hypertriglyceridemia p<0.05 OR 1.78; 61.3% elevated HbA1c p=0.48; 86.3% elevated LDL p>0.05 and 93.8% Increased ferritin p<0.05 OR 11.8.</p><p><strong>Clinical: </strong>Metabolic syndrome p<0.05 1.22 (0.9-1.44) and within the comorbidities 62.5% had diabetes mellitus p=0.26. After logistic regression analysis: Ferritin, decreased HDL and hypertriglyceridemia with a value of p<0.05.</p><p><strong>Conclusions: </strong>Increased ferritin, decreased HDL, and hypertriglyceridemia influence the risk of developing metabolic dysfunction associated with steatohepatitis with advanced fibrosis in lean patients treated at the Hospital Nacional Dos de Mayo 2012-2022.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"16-23"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparison of two maneuvers to identify Carnett's sign in patients with chronic abdominal pain. Randomized controlled clinical trial]. 两种方法鉴别慢性腹痛患者Carnett征象的比较。随机对照临床试验]。
William Otero Regino, Gilberto Jaramillo Trujillo, Lina Otero Parra, Hernando Marulanda Fernández, Juan Sebastián Frías, Julián Cardona González, Elder Otero Ramos

Introduction: Chronic abdominal pain (CAP) is a challenge in daily consultation. The most frequent cause is anterior cutaneous nerve entrapment syndrome (ACNES), which is diagnosed when the Carnett sign is positive. There are two ways to identify the Carnett sign: elevating the head and trunk or elevating the lower extremities. To date, these two ways of looking for the Carnett sign have not been compared.

Objective: To compare the effectiveness of the two maneuvers to identify the Carnett sign, evaluate the effectiveness of infiltration of the tender points with 2% lidocaine, and estimate the cost of examinations before diagnosis.

Material and methods: Randomized controlled study.

Results: 1320 patients were included and 660 patients were randomly assigned to group A: elevation of the head and trunk and 660 to group B: elevation of the lower extremities. Both maneuvers were similarly effective in identifying the Carnett sign. Infiltration of the points produced immediate relief in most patients. The costs of different studies before definitive diagnosis were approximately US$ 861 000 (dollars) versus US$ 66.00, which would be equivalent to 7.6% of the expenses incurred for tests performed before diagnosis.

Conclusion: The two ways of exploring the Carnett sign have similar efficacy. Infiltration with 2% lidocaine produced rapid and significant improvement of pain with minimal side effects. Not knowing the Carnett sign increases health costs.

慢性腹痛(CAP)是一个挑战,在日常咨询。最常见的原因是前皮神经卡压综合征(ACNES),当Carnett征象呈阳性时诊断。有两种方法来识别卡耐特标志:抬高头部和躯干或抬高下肢。迄今为止,这两种寻找卡尼特符号的方法还没有被比较过。目的:比较两种手法识别Carnett征象的效果,评价2%利多卡因浸润压痛点的效果,估计诊断前检查的费用。材料与方法:随机对照研究。结果:纳入1320例患者,其中660例患者随机分为A组:头干抬高组,660例患者随机分为B组:下肢抬高组。这两种动作在识别卡耐特标志方面同样有效。对大多数患者来说,穴位浸润能立即缓解疼痛。确诊前进行不同研究的费用约为86.1万美元,而确诊前进行不同研究的费用为66.00美元,相当于诊断前进行检测费用的7.6%。结论:两种探查Carnett征象的方法疗效相近。2%利多卡因浸润后疼痛迅速显著改善,副作用最小。不知道卡耐特标志会增加医疗成本。
{"title":"[Comparison of two maneuvers to identify Carnett's sign in patients with chronic abdominal pain. Randomized controlled clinical trial].","authors":"William Otero Regino, Gilberto Jaramillo Trujillo, Lina Otero Parra, Hernando Marulanda Fernández, Juan Sebastián Frías, Julián Cardona González, Elder Otero Ramos","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic abdominal pain (CAP) is a challenge in daily consultation. The most frequent cause is anterior cutaneous nerve entrapment syndrome (ACNES), which is diagnosed when the Carnett sign is positive. There are two ways to identify the Carnett sign: elevating the head and trunk or elevating the lower extremities. To date, these two ways of looking for the Carnett sign have not been compared.</p><p><strong>Objective: </strong>To compare the effectiveness of the two maneuvers to identify the Carnett sign, evaluate the effectiveness of infiltration of the tender points with 2% lidocaine, and estimate the cost of examinations before diagnosis.</p><p><strong>Material and methods: </strong>Randomized controlled study.</p><p><strong>Results: </strong>1320 patients were included and 660 patients were randomly assigned to group A: elevation of the head and trunk and 660 to group B: elevation of the lower extremities. Both maneuvers were similarly effective in identifying the Carnett sign. Infiltration of the points produced immediate relief in most patients. The costs of different studies before definitive diagnosis were approximately US$ 861 000 (dollars) versus US$ 66.00, which would be equivalent to 7.6% of the expenses incurred for tests performed before diagnosis.</p><p><strong>Conclusion: </strong>The two ways of exploring the Carnett sign have similar efficacy. Infiltration with 2% lidocaine produced rapid and significant improvement of pain with minimal side effects. Not knowing the Carnett sign increases health costs.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"8-15"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Unusual etiology of lower digestive bleeding in a patient with constipation]. 【便秘患者下消化道出血的不寻常病因】。
Luis Enrique Flores-Egocheaga, Eloy Puente De La Vega-Cáceres, Álvaro Bellido-Caparó

The stercoral colitis is an inflammatory caused by fecal impactation. The etiology is poorly managed chronic constipation in specific risk groups. Patients usually present with abdominal pain, abdominal distension, and fever; in severe cases, peritoneal signs, shock or multiorgan failure may occur. It is important to have a high index of suspicion and request an abdominal CT scan with contrast. Treatment is conservative in the absence of peritoneal signs or hemodynamic instability; otherwise, management is surgical. We present the case of an 86-year-old male with a history of ischemic stroke, dysmobility and chronic constipation that presented with hematochezia. The imaging study showed thickening of the wall of the distal sigmoid colon and rectum, as well as feces inside. The endoscopic study revealed ulcers in the rectum and the recto-sigmoid junction. Conservative treatment with enemas and laxatives was indicated, with favorable clinical evolution.

后珊瑚结肠炎是一种由粪便撞击引起的炎症。病因是在特定危险人群中管理不善的慢性便秘。患者通常表现为腹痛、腹胀和发热;严重者可出现腹膜体征、休克或多器官功能衰竭。重要的是要有高度的怀疑指数,并要求腹部CT扫描与对比。在没有腹膜体征或血流动力学不稳定的情况下,保守治疗;否则,管理就是外科手术。我们提出的情况下,86岁的男性缺血性中风,运动障碍和慢性便秘的历史,并提出了便血。影像学检查显示远端乙状结肠和直肠壁增厚,内可见粪便。内窥镜检查显示直肠和直肠-乙状结肠交界处有溃疡。保守治疗包括灌肠和泻药,临床进展良好。
{"title":"[Unusual etiology of lower digestive bleeding in a patient with constipation].","authors":"Luis Enrique Flores-Egocheaga, Eloy Puente De La Vega-Cáceres, Álvaro Bellido-Caparó","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The stercoral colitis is an inflammatory caused by fecal impactation. The etiology is poorly managed chronic constipation in specific risk groups. Patients usually present with abdominal pain, abdominal distension, and fever; in severe cases, peritoneal signs, shock or multiorgan failure may occur. It is important to have a high index of suspicion and request an abdominal CT scan with contrast. Treatment is conservative in the absence of peritoneal signs or hemodynamic instability; otherwise, management is surgical. We present the case of an 86-year-old male with a history of ischemic stroke, dysmobility and chronic constipation that presented with hematochezia. The imaging study showed thickening of the wall of the distal sigmoid colon and rectum, as well as feces inside. The endoscopic study revealed ulcers in the rectum and the recto-sigmoid junction. Conservative treatment with enemas and laxatives was indicated, with favorable clinical evolution.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"71-74"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ecoendoscopy guided hepaticogastrostomy for management of hepatolithiasis and anastomotic stricture after Roux en Y hepaticojejunostomy]. [生态内镜引导下肝胃造口术治疗Roux en Y肝空肠造口术后肝结石及吻合口狭窄]。
Juan Antonio Chirinos-Vega, Oscar Eduardo Ponce de León Molina

Endoscopic ultrasound-guided anterograde cholangiopancreatography (EUS-guided APC) allow us to address pathologies of the bile duct that are not treatable by endoscopic retrograde cholangiography (ERCP), such as: post-surgical benign strictures in altered anatomy, hepatolithiasis, gastric outlet obstruction, among others. Previously, when ERCP was not effective, surgical interventions such as Hepaticojejunostomy (HJ) or percutaneous transperietohepatic drainage (PTHD) were resorted to. However, EUS-guided APC has been shown to have greater clinical success, be less invasive and have a lower incidence of complications. We present the case of a 61-years-old patient with a history of HJ bypass surgery who presented abdominal pain due to hepatholitiasis and post-anastomosis benign biliary stricture, in whom the antegrade technique was performed by endoscopic ultrasound through the proximal stomach, called hepaticogastrostomy (HG) with good results.

超声内镜引导下的顺行胆管造影(eus引导下的APC)使我们能够解决内镜逆行胆管造影(ERCP)无法治疗的胆管病变,如:手术后解剖结构改变的良性狭窄、肝内胆管结石、胃出口梗阻等。以前,当ERCP无效时,采用手术干预,如肝空肠吻合术(HJ)或经皮经表肝引流术(PTHD)。然而,eus引导的APC已被证明具有更大的临床成功,侵入性更小,并发症发生率更低。我们报告了一个61岁的病人,他有HJ搭桥手术的病史,由于肝胆管炎和吻合后良性胆道狭窄而出现腹痛,他通过内镜超声通过近端胃行顺行技术,称为肝胃造口术(HG),效果良好。
{"title":"[Ecoendoscopy guided hepaticogastrostomy for management of hepatolithiasis and anastomotic stricture after Roux en Y hepaticojejunostomy].","authors":"Juan Antonio Chirinos-Vega, Oscar Eduardo Ponce de León Molina","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Endoscopic ultrasound-guided anterograde cholangiopancreatography (EUS-guided APC) allow us to address pathologies of the bile duct that are not treatable by endoscopic retrograde cholangiography (ERCP), such as: post-surgical benign strictures in altered anatomy, hepatolithiasis, gastric outlet obstruction, among others. Previously, when ERCP was not effective, surgical interventions such as Hepaticojejunostomy (HJ) or percutaneous transperietohepatic drainage (PTHD) were resorted to. However, EUS-guided APC has been shown to have greater clinical success, be less invasive and have a lower incidence of complications. We present the case of a 61-years-old patient with a history of HJ bypass surgery who presented abdominal pain due to hepatholitiasis and post-anastomosis benign biliary stricture, in whom the antegrade technique was performed by endoscopic ultrasound through the proximal stomach, called hepaticogastrostomy (HG) with good results.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"79-83"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Endoscopic retrograde cholangiopancreatography in total situs inversus, case report with focus on endoscopic technique]. [内窥镜逆行胆管造影在全倒位,病例报告,重点是内窥镜技术]。
Hernando Marulanda Fernandez, Juan Sebastian Frías-Ordoñez, Jean Sebastian Barrero Gómez, William Otero Regino

This case report describes an ERCP performed on a patient with situs inversus totalis and choledocholithiasis, highlighting the technical adaptations implemented and those described in the literature to overcome anatomical challenges and achieve a successful intervention. The experience presented in this case underscores the importance of technical and the expertise of the endoscopist in managing complex procedures in patients with unusual anatomical variations.

本病例报告描述了对完全性倒位和胆总管结石患者实施的ERCP,强调了实施的技术适应和文献中描述的克服解剖学挑战并实现成功干预的技术适应。本病例的经验强调了内窥镜医师在处理异常解剖变异患者的复杂手术时的技术和专业知识的重要性。
{"title":"[Endoscopic retrograde cholangiopancreatography in total situs inversus, case report with focus on endoscopic technique].","authors":"Hernando Marulanda Fernandez, Juan Sebastian Frías-Ordoñez, Jean Sebastian Barrero Gómez, William Otero Regino","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This case report describes an ERCP performed on a patient with situs inversus totalis and choledocholithiasis, highlighting the technical adaptations implemented and those described in the literature to overcome anatomical challenges and achieve a successful intervention. The experience presented in this case underscores the importance of technical and the expertise of the endoscopist in managing complex procedures in patients with unusual anatomical variations.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"60-65"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical practice guideline for the management of patients with heaptocellular carcinoma in the Peruvian Social Security (EsSalud)]. 【秘鲁社会保障局(EsSalud)肝细胞癌患者管理临床实践指南】。
Javier Díaz-Ferrer, Carolina J Delgado-Flores, Edgar Fermin Yan-Quiroz, Carol Gonzales-Gonzales, Carlos Arroyo-Basto, Tayana Bedregal-Mendoza, Cecilia Yerén-Paredes, Sheyla Alfaro-Ita, José A Velasquez-Barbachan, Daniel Fernandez-Guzman, Alvaro Taype-Rondan, Joan Caballero-Luna, Fabiola Huaroto-Ramírez

Introduction: This article summarizes the clinical practice guide (CPG) for management of patients with hepatocellular carcinoma (HCC) in the Social Security of Peru (EsSalud).

Objective: To provide evidence-based clinical recommendations for management of patients with HCC in EsSalud.

Materials and methods: A guideline development group (GDG) was formed, which included specialist physicians and methodologists, who formulated clinical questions. Systematic searches of systematic reviews were conducted and - when deemed relevant - primary studies in PubMed during 2024. Evidence was selected to answer each of the proposed clinical questions. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. In periodic working meetings, the GDG used the GRADE methodology to review the evidence and formulate recommendations, points of good clinical practice, and flowcharts. Finally, the CPG was approved with Resolution No. 53-IETSI-ESSALUD-2024.

Results: The CPG addressed 8 clinical questions regarding management of patients with HCC. Based on these questions, 9 recommendations were formulated (8 conditional, 1 based on a Preliminary Health Technology Assessment Opinion), 12 points of good clinical practice, and 1 flow chart.

Conclusion: Evidence-based recommendations were statement for the management of patients with HCC.

简介:本文总结了秘鲁社会保障局(EsSalud)肝细胞癌(HCC)患者管理的临床实践指南(CPG)。目的:为山东省肝癌患者的治疗提供循证临床建议。材料和方法:成立了一个指南制定小组(GDG),其中包括专家医生和方法学家,他们制定临床问题。在2024年期间,对PubMed上的系统评价进行了系统搜索,并在认为相关的情况下进行了初步研究。选择证据来回答每个提出的临床问题。证据的确定性采用分级建议评估、发展和评价(GRADE)方法进行评估。在定期工作会议上,GDG使用GRADE方法审查证据并制定建议、良好临床实践要点和流程图。最后,CPG以第53-IETSI-ESSALUD-2024号决议获得批准。结果:CPG解决了HCC患者治疗的8个临床问题。根据这些问题,制定了9项建议(8项有条件建议,1项基于《卫生技术初步评价意见》),12项临床良好做法,1个流程图。结论:基于证据的建议是HCC患者治疗的声明。
{"title":"[Clinical practice guideline for the management of patients with heaptocellular carcinoma in the Peruvian Social Security (EsSalud)].","authors":"Javier Díaz-Ferrer, Carolina J Delgado-Flores, Edgar Fermin Yan-Quiroz, Carol Gonzales-Gonzales, Carlos Arroyo-Basto, Tayana Bedregal-Mendoza, Cecilia Yerén-Paredes, Sheyla Alfaro-Ita, José A Velasquez-Barbachan, Daniel Fernandez-Guzman, Alvaro Taype-Rondan, Joan Caballero-Luna, Fabiola Huaroto-Ramírez","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>This article summarizes the clinical practice guide (CPG) for management of patients with hepatocellular carcinoma (HCC) in the Social Security of Peru (EsSalud).</p><p><strong>Objective: </strong>To provide evidence-based clinical recommendations for management of patients with HCC in EsSalud.</p><p><strong>Materials and methods: </strong>A guideline development group (GDG) was formed, which included specialist physicians and methodologists, who formulated clinical questions. Systematic searches of systematic reviews were conducted and - when deemed relevant - primary studies in PubMed during 2024. Evidence was selected to answer each of the proposed clinical questions. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. In periodic working meetings, the GDG used the GRADE methodology to review the evidence and formulate recommendations, points of good clinical practice, and flowcharts. Finally, the CPG was approved with Resolution No. 53-IETSI-ESSALUD-2024.</p><p><strong>Results: </strong>The CPG addressed 8 clinical questions regarding management of patients with HCC. Based on these questions, 9 recommendations were formulated (8 conditional, 1 based on a Preliminary Health Technology Assessment Opinion), 12 points of good clinical practice, and 1 flow chart.</p><p><strong>Conclusion: </strong>Evidence-based recommendations were statement for the management of patients with HCC.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"84-92"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Colangioscopia como alternativa terapéutica para el retiro de stents biliares con migración proximal: reporte de caso]. [血管镜作为近端移动性胆管支架移除的替代治疗:病例报告]。
Lázaro Arango Molano, Andrés Sánchez Gil, Santiago Salazar Ochoa, Gian Núñez Rojas, Herney Solarte Pineda

Endoscopic biliary plastic stent placement is standard therapy for biliary obstruction secondary to benign and malignant diseases. Complications associated with its placement are low, but potentially dangerous for the patient, especially those associated with proximal migration of the stent in the bile duct, which requires additional manipulations of the bile duct for its extraction using standard methods through endoscopic retrograde cholangiopancreatography in most patients. We present the clinical case of a patient with proximal migration and impaction of a plastic biliary stent, which required the use of advanced endoscopic techniques through cholangioscopy for its extraction.

内镜下胆道塑料支架置入术是良恶性疾病继发胆道梗阻的标准治疗方法。置入支架的并发症很低,但对患者有潜在的危险,特别是那些与胆管近端支架移位相关的并发症,在大多数患者中,这需要通过内镜逆行胆管造影术的标准方法对胆管进行额外的操作。我们提出的临床病例的病人近端移动和嵌塞的一个塑料胆道支架,这需要使用先进的内镜技术,通过胆道镜提取其。
{"title":"[Colangioscopia como alternativa terapéutica para el retiro de stents biliares con migración proximal: reporte de caso].","authors":"Lázaro Arango Molano, Andrés Sánchez Gil, Santiago Salazar Ochoa, Gian Núñez Rojas, Herney Solarte Pineda","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Endoscopic biliary plastic stent placement is standard therapy for biliary obstruction secondary to benign and malignant diseases. Complications associated with its placement are low, but potentially dangerous for the patient, especially those associated with proximal migration of the stent in the bile duct, which requires additional manipulations of the bile duct for its extraction using standard methods through endoscopic retrograde cholangiopancreatography in most patients. We present the clinical case of a patient with proximal migration and impaction of a plastic biliary stent, which required the use of advanced endoscopic techniques through cholangioscopy for its extraction.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"66-70"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[An update of the Helicobacter pylori treatment: a Latin American Gastric Cancer, Helicobacter and Microbiota Study Group review]. [幽门螺杆菌治疗的最新进展:拉丁美洲胃癌、幽门螺杆菌和微生物群研究组综述]。
William Otero R, Arnoldo Riquelme, José María Remes-Troche, Oscar Laudanno, Alejandro Piscoya, Hernando Marulanda, Lina Otero, Diego Reyes-Placencia

Helicobacter pylori (H. pylori) is the primary etiological agent of gastric adenocarcinoma, which affects over 60% of the global population, with a significant prevalence in Latin America. Given its impact on the affected population, it is crucial to understand the diagnostic tools available for detecting this infection. While clarithromycin-based therapies are still widely used, the high rates of resistance to this antibiotic in the region needs the establishment of alternative, more effective treatments as the standard of care, such as bismuth-based quadruple therapy or high-dose dual therapy with amoxicillin. In cases of refractory infection, local data registries are valuable for informed decision-making.

幽门螺杆菌(h.p ylori)是胃腺癌的主要病因,影响全球60%以上的人口,其中拉丁美洲的患病率很高。鉴于其对受影响人群的影响,了解可用于检测这种感染的诊断工具至关重要。虽然以克拉霉素为基础的疗法仍在广泛使用,但该区域对这种抗生素的高耐药率需要建立替代的、更有效的治疗方法作为标准护理,例如以铋为基础的四联疗法或阿莫西林的高剂量双重疗法。在难治性感染的情况下,当地数据登记对知情决策很有价值。
{"title":"[An update of the Helicobacter pylori treatment: a Latin American Gastric Cancer, Helicobacter and Microbiota Study Group review].","authors":"William Otero R, Arnoldo Riquelme, José María Remes-Troche, Oscar Laudanno, Alejandro Piscoya, Hernando Marulanda, Lina Otero, Diego Reyes-Placencia","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Helicobacter pylori (H. pylori) is the primary etiological agent of gastric adenocarcinoma, which affects over 60% of the global population, with a significant prevalence in Latin America. Given its impact on the affected population, it is crucial to understand the diagnostic tools available for detecting this infection. While clarithromycin-based therapies are still widely used, the high rates of resistance to this antibiotic in the region needs the establishment of alternative, more effective treatments as the standard of care, such as bismuth-based quadruple therapy or high-dose dual therapy with amoxicillin. In cases of refractory infection, local data registries are valuable for informed decision-making.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"44 4","pages":"359-373"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Premedication in upper gastrointestinal endoscopy to improve mucosal visualization. A systematic review. 上消化道内窥镜前用药改善粘膜显像。系统回顾。
Juan David Linares-Ramírez, Andrea Carolina Córdoba, Carlos Hernán Calderón-Franco, Diego Mauricio Aponte-Martín, Fabian Dávila, Luis Carlos Sabbagh

Objective: This review aims to evaluate the efficacy and safety of premedication comprising mucolytics and/or defoaming agents to improve the quality of visualization during elective upper digestive endoscopy (elective upper GI endoscopy) procedure.

Materials and methods: A systematic review of the literature contained in electronic databases (Medline/Pubmed, Embase, and Lilacs) was performed to identify randomized controlled trials and systematic reviews that assessed patients undergoing upper gastrointestinal endoscopy (elective upper GI Endoscopy) under sedation, after being premedicated with mucolytics and/or defoaming agents for mucous clearance. A meta-analysis was conducted to determine the relative efficacy and safety profile of such premedication.

Results: In patients undergoing an elective procedure, premedication with defoaming and/or mucolytic agents improved the visibility score of the gastric antrum during upper GI endoscopy. The use of combined agents such as simethicone vs. water and N-acetyl cysteine (NAC) vs. water showed significant differences in favor of the active substance; however, no significant differences were found between the use of simethicone alone vs. simethicone + NAC. The use of pronase and dimethylpolysiloxane, among others, produced no significant difference (additive effect) in the visualization score. This is associated with the limited number of studies that performed similar comparisons and the heterogeneity of the outcomes. No major adverse effects were reported in the studies that were included regarding safety outcomes (i.e., volume of fluids required for clearance, risk of bronchoaspiration, and disinfection of equipment).

Conclusions: The results of this review evidence that premedication with simethicone (a drug registered in Colombia for use against functional gastrointestinal disorders; ATC group A03A) is safe and effective for improving the quality of visualization during elective upper GI endoscopy procedures. However, no significant differences were observed in the visualization quality with the use or addition of other agents. The use simethicone should be set as off-label use and should be implemented at the prescriber's discretion. The use of simethicone as a premedication is recommended to improve the endoscopic visualization score in elective procedures.

目的:本综述旨在评价在选择性上消化道内镜检查(选择性上消化道内镜)过程中,使用含有黏液溶解剂和/或消泡剂的预用药来改善可视化质量的有效性和安全性。材料和方法:对电子数据库(Medline/Pubmed、Embase和Lilacs)中包含的文献进行系统回顾,以确定随机对照试验和系统回顾,这些试验和系统回顾评估了在镇静下接受上消化道内镜检查(选择性上消化道内镜)的患者,在预先使用黏液溶解剂和/或消泡剂清除黏液后。进行了一项荟萃分析,以确定这种预用药的相对疗效和安全性。结果:在接受选择性手术的患者中,在进行上消化道内镜检查时,预先使用消泡剂和/或黏液溶解剂可改善胃窦的可见性评分。西甲硅氧烷对水和n -乙酰半胱氨酸(NAC)对水的联合使用显示出有利于活性物质的显著差异;然而,在单独使用西甲硅氧烷与西甲硅氧烷+ NAC之间没有发现显著差异。使用pronase和二甲基聚硅氧烷等,在可视化评分上没有显著差异(加性效应)。这与进行类似比较的研究数量有限以及结果的异质性有关。纳入的研究在安全性结果(即清除所需的液体量、支气管吸入风险和设备消毒)方面未报告重大不良反应。结论:本综述的结果表明,用药前使用西甲硅氧烷(一种在哥伦比亚注册用于治疗功能性胃肠疾病的药物);ATC组(A03A)对于提高选择性上消化道内镜检查的可视化质量是安全有效的。然而,使用或添加其他药物在可视化质量上没有明显差异。西甲硅氧烷的使用应设定为标签外使用,并应在处方者的自由裁量权下实施。建议在选择性手术中使用西甲硅氧烷作为前用药,以提高内镜观察评分。
{"title":"Premedication in upper gastrointestinal endoscopy to improve mucosal visualization. A systematic review.","authors":"Juan David Linares-Ramírez, Andrea Carolina Córdoba, Carlos Hernán Calderón-Franco, Diego Mauricio Aponte-Martín, Fabian Dávila, Luis Carlos Sabbagh","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>This review aims to evaluate the efficacy and safety of premedication comprising mucolytics and/or defoaming agents to improve the quality of visualization during elective upper digestive endoscopy (elective upper GI endoscopy) procedure.</p><p><strong>Materials and methods: </strong>A systematic review of the literature contained in electronic databases (Medline/Pubmed, Embase, and Lilacs) was performed to identify randomized controlled trials and systematic reviews that assessed patients undergoing upper gastrointestinal endoscopy (elective upper GI Endoscopy) under sedation, after being premedicated with mucolytics and/or defoaming agents for mucous clearance. A meta-analysis was conducted to determine the relative efficacy and safety profile of such premedication.</p><p><strong>Results: </strong>In patients undergoing an elective procedure, premedication with defoaming and/or mucolytic agents improved the visibility score of the gastric antrum during upper GI endoscopy. The use of combined agents such as simethicone vs. water and N-acetyl cysteine (NAC) vs. water showed significant differences in favor of the active substance; however, no significant differences were found between the use of simethicone alone vs. simethicone + NAC. The use of pronase and dimethylpolysiloxane, among others, produced no significant difference (additive effect) in the visualization score. This is associated with the limited number of studies that performed similar comparisons and the heterogeneity of the outcomes. No major adverse effects were reported in the studies that were included regarding safety outcomes (i.e., volume of fluids required for clearance, risk of bronchoaspiration, and disinfection of equipment).</p><p><strong>Conclusions: </strong>The results of this review evidence that premedication with simethicone (a drug registered in Colombia for use against functional gastrointestinal disorders; ATC group A03A) is safe and effective for improving the quality of visualization during elective upper GI endoscopy procedures. However, no significant differences were observed in the visualization quality with the use or addition of other agents. The use simethicone should be set as off-label use and should be implemented at the prescriber's discretion. The use of simethicone as a premedication is recommended to improve the endoscopic visualization score in elective procedures.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"44 4","pages":"346-353"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1